Zeposia Evropska unija - slovenščina - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod hidroklorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresivi - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Emtricitabin/dizoproksiltenofovirat Accordpharma 200 mg/245 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

emtricitabin/dizoproksiltenofovirat accordpharma 200 mg/245 mg filmsko obložene tablete

emtricitabin; tenofovir - filmsko obložena tableta - emtricitabin 200 mg / 1 tableta  tenofovir136 mg / 1 tableta; tenofovir 136 mg / 1 tableta - dizoproksiltenofovirat in emtricitabin